Yanling Wu[Author] - Search Results

Year	Number of Results
2002	1
2003	1
2004	3
2005	2
2006	3
2007	3
2008	5
2009	4
2010	12
2011	9
2012	6
2013	11
2014	12
2015	8
2016	13
2017	18
2018	14
2019	20
2020	42
2021	49
2022	44
2023	36
2024	17

1

Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.

Wu Y, Ding Y, Tanaka Y, Zhang W. Wu Y, et al. Int J Med Sci. 2014 Sep 6;11(11):1185-200. doi: 10.7150/ijms.10001. eCollection 2014. Int J Med Sci. 2014. PMID: 25249787 Free PMC article. Review.

2

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.

Li C, Zhan W, Yang Z, Tu C, Hu G, Zhang X, Song W, Du S, Zhu Y, Huang K, Kong Y, Zhang M, Mao Q, Gu X, Zhang Y, Xie Y, Deng Q, Song Y, Chen Z, Lu L, Jiang S, Wu Y, Sun L, Ying T. Li C, et al. Among authors: wu y. Cell. 2022 Apr 14;185(8):1389-1401.e18. doi: 10.1016/j.cell.2022.03.009. Epub 2022 Mar 10. Cell. 2022. PMID: 35344711 Free PMC article.

3

A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors.

Wu Y, Li Q, Kong Y, Wang Z, Lei C, Li J, Ding L, Wang C, Cheng Y, Wei Y, Song Y, Yang Z, Tu C, Ding Y, Ying T. Wu Y, et al. Mol Ther. 2022 Aug 3;30(8):2785-2799. doi: 10.1016/j.ymthe.2022.04.013. Epub 2022 Apr 22. Mol Ther. 2022. PMID: 35462042 Free PMC article.

4

Antibody-based cancer immunotherapy by targeting regulatory T cells.

Li Q, Lu J, Li J, Zhang B, Wu Y, Ying T. Li Q, et al. Among authors: wu y. Front Oncol. 2023 Apr 27;13:1157345. doi: 10.3389/fonc.2023.1157345. eCollection 2023. Front Oncol. 2023. PMID: 37182149 Free PMC article. Review.

5

Two-dimensional chalcogenide-based ferromagnetic semiconductors.

Wu Y, Li J, Liu Y. Wu Y, et al. J Phys Condens Matter. 2022 Dec 21;35(8). doi: 10.1088/1361-648X/acaa7e. J Phys Condens Matter. 2022. PMID: 36540916 Review.

6

Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction.

Li T, Li Y, Zhu X, He Y, Wu Y, Ying T, Xie Z. Li T, et al. Among authors: wu y. Semin Cancer Biol. 2023 Jun;91:50-69. doi: 10.1016/j.semcancer.2023.02.007. Epub 2023 Mar 3. Semin Cancer Biol. 2023. PMID: 36870459 Review.

7

The regulatory role of adipocyte mitochondrial homeostasis in metabolism-related diseases.

Song H, Zhang X, Wang J, Wu Y, Xiong T, Shen J, Lin R, Xiao T, Lin W. Song H, et al. Among authors: wu y. Front Physiol. 2023 Oct 18;14:1261204. doi: 10.3389/fphys.2023.1261204. eCollection 2023. Front Physiol. 2023. PMID: 37920803 Free PMC article. Review.

8

Current advances in the development of SARS-CoV-2 vaccines.

Awadasseid A, Wu Y, Tanaka Y, Zhang W. Awadasseid A, et al. Among authors: wu y. Int J Biol Sci. 2021 Jan 1;17(1):8-19. doi: 10.7150/ijbs.52569. eCollection 2021. Int J Biol Sci. 2021. PMID: 33390829 Free PMC article. Review.

9

Promoter Architecture and Promoter Engineering in Saccharomyces cerevisiae.

Tang H, Wu Y, Deng J, Chen N, Zheng Z, Wei Y, Luo X, Keasling JD. Tang H, et al. Among authors: wu y. Metabolites. 2020 Aug 6;10(8):320. doi: 10.3390/metabo10080320. Metabolites. 2020. PMID: 32781665 Free PMC article. Review.

10

New Advances in Canonical Wnt/β-Catenin Signaling in Cancer.

Wen X, Wu Y, Awadasseid A, Tanaka Y, Zhang W. Wen X, et al. Among authors: wu y. Cancer Manag Res. 2020 Aug 6;12:6987-6998. doi: 10.2147/CMAR.S258645. eCollection 2020. Cancer Manag Res. 2020. PMID: 32821165 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

302 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Results by year